SCHEMBL8439752

SCHEMBL8439752

COc1cc(CC(=O)N2CCc3occc3C2)ccc1OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.58
NPC1 O15118 5/20 0.58
MEN1 O00255 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
KDM4E B2RXH2 3/20 0.49
LMNA P02545 1/20 0.49
TSHR P16473 1/20 0.49
HTT P42858 1/20 0.47
APP P05067 3/20 0.47
HPGD P15428 2/20 0.47
ABCB1 P08183 1/20 0.47
ABCC1 P33527 1/20 0.47
GPR183 P32249 1/20 0.46
RAB9A P51151 4/20 0.46
ALDH1A1 P00352 2/20 0.46
ABL1 P00519 1/20 0.46
RIN1 Q13671 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.45
PKM P14618 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8436351 0.93 KMT2A (0.58) KMT2ANPC1MEN1SMN1; SMN2KDM4E
SCHEMBL9416631 0.85 KMT2A (0.76) KMT2ANPC1MEN1SMN1; SMN2KDM4E
SCHEMBL8437814 0.83 KMT2A (0.52) KMT2ANPC1MEN1SMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL8434968 0.82 KMT2A (0.52) KMT2ANPC1MEN1SMN1; SMN2KDM4E
SCHEMBL8437426 0.79 KMT2A (0.52) KMT2ANPC1MEN1SMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL8440804 0.78 KMT2A (0.52) KMT2ANPC1MEN1SMN1; SMN2KDM4E
SCHEMBL8805114 0.75 CHRNA7 (0.42) KMT2ANPC1MEN1SMN1; SMN2KDM4E
SCHEMBL23315583 0.73 NPC1 (0.62) KMT2ANPC1KDM4EABCB1ABCC1
SCHEMBL31011346 0.72 NPC1 (0.63) KMT2ANPC1MEN1SMN1; SMN2TSHR
SCHEMBL1114985 0.72 NPC1 (0.63) KMT2ANPC1MEN1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5998433-A THERAPY FOR HYPERLIPIDEMIA; ATHEROSCLEROSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-12-07 US disclosed
CN-1160403-A Substd. heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-09-24 CN disclosed
EP-0785939-A1 SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 1997-07-30 EP disclosed
WO-1996011201-A1 SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-04-18 WO disclosed